Latest news
BriaCell Receives FDA Clearance to Initiate Bria-PROS+ Clinical Study in Prostate Cancer - Investing News NetworkInvesting News Network · Wed, 05 Aug 2026 12:47:14 GMTAkebia Therapeutics Announces Initiation of a Phase 2 Basket Trial to Study Ebribafusp, a Next-Generation Complement Inhibitor in Rare Kidney Diseases - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 12:00:00 GMTExclusive BAC Article: Altimmune; Ph 3 MASH Study Initiation Pemvidutide Q3 2026, Positive AUD Data Leads To EOP2 Meeting, Additional Expansion Potential, And Catalysts (NASDAQ:ALT) - Seeking AlphaSeeking Alpha · Tue, 28 Jul 2026 18:31:48 GMT